why choose us

First received: May 15, 2023

Clinical Trial: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Brief Summary: This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult participants with obesity or overweight and type 2 diabetes.The study will last about 77 weeks and may include up to 22 visits.

Read more